ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,822.00
1.24%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
97,361.41
-0.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avalo Therapeutics Inc (AVTX)

  7. Avalo Therapeutics Inc (AVTX) News

AVTX

Avalo Therapeutics (AVTX)

Avalo Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVTX
DateTimeSourceHeadlineSymbolCompany
12/05/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
11/14/202412:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
11/12/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
11/12/20247:00AMGlobeNewswire Inc.Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement WarrantsNASDAQ:AVTXAvalo Therapeutics Inc
11/11/20247:00AMGlobeNewswire Inc.Avalo Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:AVTXAvalo Therapeutics Inc
11/07/20245:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
11/07/20247:20AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVTXAvalo Therapeutics Inc
11/07/20247:17AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVTXAvalo Therapeutics Inc
11/07/20247:04AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTXAvalo Therapeutics Inc
11/07/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
11/07/20247:00AMGlobeNewswire Inc.Avalo Reports Third Quarter 2024 Financial Results and Recent Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
10/08/20247:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
10/08/20247:00AMGlobeNewswire Inc.Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis SuppurativaNASDAQ:AVTXAvalo Therapeutics Inc
10/07/20248:06PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AVTXAvalo Therapeutics Inc
09/09/20247:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
09/09/20247:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
09/04/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
09/04/20247:00AMGlobeNewswire Inc.Avalo Announces Participation in September Investor ConferencesNASDAQ:AVTXAvalo Therapeutics Inc
08/23/20244:05PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AVTXAvalo Therapeutics Inc
08/14/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
08/14/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
08/14/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
08/14/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
08/14/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
08/14/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
08/14/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
08/12/20247:03AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTXAvalo Therapeutics Inc
08/12/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
08/12/20247:00AMGlobeNewswire Inc.Avalo Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
08/06/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AVTXAvalo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AVTX

Your Recent History

USOTC
GRLT
Grillit (PK)
USOTC
RDAR
Raadr (PK)
USOTC
AFFU
Affluence (PK)
USOTC
MGON
Megola (PK)
NASDAQ
NXPL
NextPlat
USOTC
PHIL
PHI (PK)
NASDAQ
NUKK
Nukkleus
USOTC
CBRF
CyberFuels (PK)
USOTC
GTCH
GBT Technologies (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
AMEX
KULR
KULR Technology
NASDAQ
ILLR
Triller
USOTC
SPZI
Spooz (PK)
USOTC
MONI
Moon Equity (PK)
NYSE
AMC
AMC Entertainment
COIN
SHIBUSD
SHIBA INU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads